Lipid nanoparticles delivering constitutively active STING mRNA as a novel anti-cancer therapeutic approach
Liu, W.; Alameh, M.-G.; Yang, J. F.; Xu, J. R.; Lin, P. J.; Tam, Y. K.; Weissman, D.; You, J.
Show abstract
Treating immunosuppressive tumors represents a major challenge in cancer therapies. Activation of STING signaling has shown remarkable potential to invigorate the immunologically cold tumor microenvironment (TME). However, we and others have shown that STING is silenced in many cancers, including pancreatic ductal adenocarcinoma (PDAC) and Merkel cell carcinoma (MCC), both of which are associated with an immune-dampened TME. In this study, we applied mRNA lipid nanoparticles (LNP) to deliver a permanently active gain-of-function STINGR284S mutant into PDAC and MCC cells. Expression of STINGR284S induces cytokines and chemokines crucial for promoting intratumoral infiltration of CD8+ T cells and, importantly, also leads to robust cancer cell death while avoiding T cell entry and toxicity. Our studies demonstrated that mRNA-LNP delivery of STINGR284S could be explored as a novel therapeutic tool to reactivate antitumor response in an array of STING-deficient cancers while overcoming the toxicity and limitations of conventional STING agonists.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The E3 ligase NEDD4L prevents colorectal cancer liver metastasis via degradation of PRMT5 to inhibit the AKT/mTOR signaling pathway 93%
- Engineered small extracellular vesicles as a FGL1/PD-L1 dual-targeting delivery system for alleviating immune rejection 93%
- Discovery of intratumoral oncolytic bacteria toward targeted anticancer theranostics 92%
Similar papers in this journal
- Single-cell transcriptome analysis of the immunosuppressive effect of differential expression of tumor PD-L1 on responding TCR-T cells 94%
- Selective targeting of an oncogenic KRAS mutant allele by CRISPR/Cas9 induces efficient tumor regression 93%
- Claudin-5 binder enhances focused ultrasound-mediated opening in an in vitro blood-brain barrier model 92%
Similar papers in this journal
- Balancing activation and costimulation of CAR tunes signaling dynamics and enhances therapeutic potency 95%
- A novel anti-PD-L1/IL-15 immunocytokine overcomes resistance to PD-L1 blockade and elicits potent antitumor immunity 94%
- Corticosteroids and cellulose purification improve respectively the in vivo translation and vaccination efficacy of self-amplifying mRNAs 93%
Similar papers in this journal
- Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle 92%
- Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy 92%
- Reversible blood-brain barrier opening utilizing the membrane active peptide melittin in vitro and in vivo 91%
Similar papers in this journal
- Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway 94%
- Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2 94%
- NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.